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Abstract
The coronavirus E protein is a small membrane protein with a single predicted hydrophobic domain (HD), and has a poorly
defined role in infection. The E protein is thought to promote virion assembly, which occurs in the Golgi region of infected
cells. It has also been implicated in the release of infectious particles after budding. The E protein has ion channel activity in
vitro, although a role for channel activity in infection has not been established. Furthermore, the membrane topology of the
E protein is of considerable debate, and the protein may adopt more than one topology during infection. We previously
showed that the HD of the infectious bronchitis virus (IBV) E protein is required for the efficient release of infectious virus, an
activity that correlated with disruption of the secretory pathway. Here we report that a single residue within the
hydrophobic domain, Thr16, is required for secretory pathway disruption. Substitutions of other residues for Thr16 were not
tolerated. Mutations of Thr16 did not impact virus assembly as judged by virus-like particle production, suggesting that
alteration of secretory pathway and assembly are independent activities. We also examined how the membrane topology of
IBV E affected its function by generating mutant versions that adopted either a transmembrane or membrane hairpin
topology. We found that a transmembrane topology was required for disrupting the secretory pathway, but was less
efficient for virus-like particle production. The hairpin version of E was unable to disrupt the secretory pathway or produce
particles. The findings reported here identify properties of the E protein that are important for its function, and provide
insight into how the E protein may perform multiple roles during infection.
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Introduction
Coronaviruses (CoVs) are enveloped, positive strand RNA
viruses that infect a variety of mammalian and avian species. In
humans, CoVs are responsible for nearly 20% of common cold
cases. CoVs can also lead to more serious disease as seen during
the outbreak of the severe acute respiratory syndrome coronavirus
(SARS-CoV) in 2003. To better prepare for the emergence of
another highly pathogenic CoV it is important to increase our
understanding of CoV biology.
The CoV virion consists of a helical nucleocapsid, made up of
the CoV N protein and the genome, surrounded by a lipid
envelope. Three structural proteins are embedded in the virion
envelope. The CoV S protein is a type I transmembrane protein
and is responsible for the attachment and fusion of the virion
during entry. The CoV M protein has three transmembrane
domains and drives the organization of the virion through its
interactions with the other structural proteins [1]. The CoV E
protein is small (76–108aa), is predicted to contain a single
hydrophobic domain (HD), and is a minor component of the
virion envelope. CoV E and CoV M drive the assembly of the
virion [2]. CoV assembly occurs intracellularly at the endoplasmic
reticulum-Golgi intermediate compartment (ERGIC) [3]. This
results in fully assembled infectious particles within the lumen of
the Golgi complex and downstream secretory organelles. Thus,
virions must use the host secretory pathway in order to reach the
plasma membrane and be released from infected cells.
In addition to its role in assembly, CoV E may have other
functions during infection. Studies in planar lipid bilayers have
shown that CoV E has ion channel activity [4,5]. These studies
also showed that the small molecule hexamethylene amiloride
(HMA) inhibits the ion channel activity of mouse hepatitis virus
(MHV) E and human coronavirus 229E (HCoV 229E) E. While
there is no direct evidence that CoV E acts as an ion channel
during infection, addition of HMA to either MHV or HCoV 229E
infected cells inhibits viral replication, and mutations introduced
into the HD of MHV E impair virus production suggesting that
the putative ion channel activity may play a role during infection
[5,6]. If CoV E acts as an ion channel, it must form higher order
structures because it contains only one predicted transmembrane
domain. Indeed, structural and computational studies have
suggested that CoV E forms a homo-pentamer in the membrane
with a pore in the middle [7–9]. Understanding the role of a
pentameric E ion channel is an important question in the field.
The membrane topology of CoV E is of considerable debate.
CoV E has a short (,10aa) hydrophilic N-terminus followed by a
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The N-terminus does not contain a canonical ER signal sequence
[10]. The hydrophobic domain is unusually long for a protein
targeted to the ERGIC/Golgi complex, but does not appear to be
long enough to span the lipid bilayer twice [11]. These properties
make it difficult to predict the topology based on the primary
sequence. Complicating matters is the fact that multiple topologies
have been reported in the literature for different CoV E proteins.
Both IBV E and SARS-CoV E have been reported to exist as a
type III transmembrane protein (Nexo,C cyto) [12,13]. Other
investigators have reported the opposite topology for SARS-CoV
E and transmissible gastroenteritis virus (TGEV) E (Ncyto,C exo)
[14,15]. Yet another topology reported for CoV E is a membrane
hairpin, where the hydrophobic domain bends into the cytoplas-
mic leaflet of the membrane with the N- and C-termini in the
cytoplasm. The hairpin topology has been reported for MHV E
and SARS-CoV E [15–17]. These discrepancies suggest that CoV
E may adopt more than one membrane topology. If this is the
case, CoV E may perform distinct functions depending on how it
is inserted into the membrane. For example, a transmembrane
version of CoV E could oligomerize and act as an ion channel,
whereas a membrane hairpin could drive virion budding.
Since CoVs assemble intracellularly, their virions must pass
through the host secretory pathway for egress. How or if the
secretory pathway is modified in infected cells is not well
understood, but may involve the E protein. A version of TGEV
lacking the E protein was unable to produce infectious particles,
but electron microscopy revealed that immature virions were
present in secretory organelles of infected cells [18]. Alanine
insertion scanning mutagenesis of the HD of MHV E produced
mutant viruses that showed a defect in the release of infectious
particles [6]. These results demonstrate that CoV E is important
for virion trafficking, but did not identify the mechanism. It has
long been appreciated that CoV infection drives a rearrangement
of host cell membranes including the Golgi complex [19]. More
recently it was shown that during CoV infection virions appear in
large virion-containing vacuoles derived from Golgi/ERGIC
membranes [20]. Recently we showed that the E protein of IBV
promotes the release of infectious particles. We also observed that
expression of IBV E results in the disruption of anterograde
protein traffic and causes the Golgi complex to disassemble, and
that all of these effects were dependent on the HD of IBV E [21].
This finding linked the efficient release of particles to the alteration
of the host secretory pathway, and demonstrated that IBV E has a
role during infection beyond assembly.
In the present study we set out to determine what properties of
the HD of IBV E were important for disrupting the secretory
pathway. We performed alanine scanning mutagenesis on the HD
and identified a key residue required for disrupting the secretory
pathway. We also addressed the role of topology in disrupting the
secretory pathway by designing mutant versions of IBV E that
adopted either a transmembrane or a membrane hairpin topology.
This allowed, for the first time, functional analysis of the two
specific forms.
Results
A Single Polar Uncharged Residue in IBV E is Necessary
for Disrupting Protein Trafficking
When the HD of IBV E (GenBank ID: CAC39117) is modeled
as an alpha helix and viewed in a helical wheel projection, polar
uncharged amino acids cluster on one side (Figure 1A). If the
cluster of polar uncharged residues is important for the
disruption of the secretory pathway, mutating them to alanine
should inhibit their effect, while mutations on the opposite side
of the helix should have no effect. To test this hypothesis, single
alanine mutations of the polar uncharged residues as well as
residues on the opposite side of the helix were made. The mutant
proteins were transiently expressed in HeLa cells and their
expression was confirmed by immunoblot (Figure 1B). Next, we
determined whether the mutants disrupted protein trafficking.
The mutant proteins were expressed along with the model cargo
protein vesicular stomatitis virus glycoprotein (VSV G). Traf-
ficking of VSV G was measured using metabolic labeling in a
pulse-chase assay coupled with endoglycosidase H (endo H)
digestion. Since glycoproteins become resistant to digestion with
endo H in the medial-Golgi, this assay monitors the rate at which
a glycoprotein moves through the Golgi complex. All of the
alanine mutants disrupted trafficking with the exception of IBV
E T16A (Figure 1 C and D). Thus, a single polar uncharged
residue within the HD of IBV E is necessary for disrupting
protein trafficking.
T16 Is Required for Disruption of the Golgi Complex
In addition to disrupting protein trafficking, IBV E expression
disrupts Golgi morphology [21]. As with the trafficking defect,
the disruption of the Golgi complex is dependent on the HD of
IBV E. We reasoned that if the trafficking defect and Golgi
complex disruption were occurring by the same process, T16
would be necessary for both effects. Indirect immunofluorescence
microscopy was performed on cells transiently expressing IBV E
or the mutant proteins. Cells were stained for IBV E and GM130,
a marker of the Golgi complex. All of the mutant proteins
disrupted the Golgi complex like IBV E with the exception of
T16A, which had no effect on Golgi complex morphology
(Figure 2A and B). These results, along with the data shown in
Figure 1, demonstrate that a single polar uncharged residue
within the HD of IBV E (T16) is necessary for the disruption of
the secretory pathway.
T16 Does Not Tolerate Substitution of Conserved Amino
Acids
We next determined if there was any flexibility in the amino
acid required at position 16 in IBV E. A multiple sequence
Author Summary
Coronaviruses are enveloped viruses that bud and
assemble intracellularly, and therefore must use the host
secretory pathway for release. Coronavirus E is a small
protein that contains a single predicted hydrophobic
domain and is targeted to the Golgi region. The E protein
has been implicated in the assembly of coronavirus
particles, as well as in virus release after assembly. The
mechanism of action is not understood, but may involve
ion channel activity. The membrane topology of the E
protein is also unclear, and the protein may adopt distinct
topologies that have different functions. We previously
showed that the E protein from the infectious bronchitis
virus could disrupt the secretory pathway to the apparent
advantage of the virus. Here we have mapped this activity
to a single, essential residue within the hydrophobic
domain. Additionally, we developed mutant versions of
IBV E that adopt a single membrane topology, and showed
that a transmembrane topology is required for disruption
of the secretory pathway. Our results broaden the
understanding of E protein function and will impact the
development of antiviral strategies.
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polar uncharged residue is conserved at position 16 (Figure 3A).
We introduced mutations at posi t i o n1 6i nI B VEt h a tr e p l a c e d
the threonine with serine, asparagine or glutamine. The mutant
proteins were transiently expressed along with VSV G to
determine their effect on protein trafficking. None of the
proteins disrupted trafficking of VSV G, showing that these
residues could not substitute for threonine (Figure 3B). We
examined the morphology of the Golgi complex in cells
expressing the mutant E proteins using indirect immunofluo-
rescence microscopy. Corroborating the trafficking results,
none of the conserved mutations disrupted Golgi complex
morphology as judged by GM130 staining (Figure 3C). Thus,
there is a strict requirement for threonine at position 16 in IBV
E.
E Proteins with Mutations at T16 Support Virus-Like
Particle Production
Previously we reported that replacing the sequence of the HD of
IBV E does not affect virus-like particle (VLP) production [22].
However, since these earlier experiments were carried out using a
different cell type and expression system, we wanted to confirm
that mutating T16 did not impair VLP production. We co-
expressed IBV E and the T16 mutants along with plasmids
encoding IBV M and IBV N in HeLa cells. The supernatant and
cells were collected separately, and VLPs were purified from the
supernatant via centrifugation over a sucrose cushion. The level of
VLPs produced was measured by immunoblotting and comparing
the signal for M in the VLP fraction to the cell fraction. We found
that none of the mutations had a significant impact on steady-state
VLP production as judged by the amount of M released (Figure 4A
Figure 1. A single polar uncharged residue in IBV E is required for disruption of cargo trafficking. (A) A helical wheel diagram of the HD
of IBV E. Polar uncharged residues are shown in blue; residues mutated to alanine are outlined in red. (B) An immunoblot shows that the alanine
mutants of IBV E are expressed and run at a similar molecular weight when transiently expressed in HeLa cells. (C) VSV G was transiently co-expressed
with the indicated protein in HeLa cells. 18–22 hours after transfection the cells were pulse-labeled with
35S-methionine/cysteine and chased for 0,
25, and 50 min. VSV G was immunoprecipitated from each sample and digested with endoglycosidase H. The mature (**) and immature (*) forms are
indicated. Data from control, IBV E, S13A, and T16 A is shown. (D) Quantification of (C) showing that the T16A mutation inactivates the trafficking
block. At each time-point the signal intensity for the mature and immature bands was measured. The percent of endo H resistant VSV G was
calculated by dividing the signal for the mature band by the total signal (mature+immature). Data are from at least two independent experiments.
Error bars represent +/2 SEM.
doi:10.1371/journal.ppat.1002674.g001
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but is not required for VLP production.
Effect of Other CoV E Proteins on the Secretory Pathway
CoVs fall into three distinct groups based on genome
similarities, alpha, beta and gamma. IBV is a gamma-CoV, and
we wanted to determine if the effect on the secretory pathway was
a property of other CoV E proteins. We transiently expressed the
E proteins from the beta-CoVs SARS-CoV (GenBank ID:
NP_828854.1) and MHV (GenBank ID: ACO72886) as well as
the alpha-CoV TGEV (GenBank ID: ABG89321) in HeLa cells.
Using antibodies directed against the various CoV E proteins or
GM130, the morphology of the Golgi complex was examined.
Somewhat surprisingly, none of the other CoV E proteins caused
the Golgi complex to disassemble (Figure S1). Other markers for
the Golgi complex were also distributed normally (data not
shown). We determined if any of the other CoV E proteins
impacted protein traffic through the Golgi complex using the
pulse-chase endo H assay described above. VSV G trafficking was
unaffected by expression of any of these E proteins (data not
shown). Taken together these data indicate that the effect of
SARS-CoV E, MHV E, and TGEV E on the host secretory
pathway may be different than that of IBV E, and potentially point
to an important difference in the function of the proteins.
However, we found that the half-life of IBV E was longer (3.6 h)
than that of MHV E (2 h), SARS-CoV E (2.1 h), or TGEV E
(2.6 h) (data not shown). Additionally, we could not compare the
absolute expression level of each protein (since the antibodies to
detect each one are different). Thus, it is possible that MHV E,
SARS-CoV E and TGEV E do not accumulate to as high a level
as IBV E in this expression system, and therefore do not
demonstrate the disruption in the secretory pathway observed
for IBV E.
Generation of IBV E Mutants That Adopt Either a
Transmembrane or Membrane Hairpin Topology
Multiple groups have proposed different membrane topologies
for the CoV E protein, either as a transmembrane protein or as a
membrane hairpin (Figure 5B, cartoons) [10,12–16]. It is possible
that CoV E may adopt multiple membrane topologies, each with
distinct function(s). To test the role of topology in IBV E function,
mutant versions of IBV E were created with either a transmem-
brane or membrane hairpin topology. To promote a transmem-
brane topology we added a canonical cleavable N-terminal signal
sequence onto the N-terminus of IBV E (ssIBV E), which will force
the cleaved N-terminus into the ER lumen [23,24]. To produce a
potential membrane hairpin we added a FLAG tag onto the N-
terminus (FLAG-IBVE). The rationale for this was that other N-
terminally FLAG tagged CoV E proteins adopt a membrane
hairpin topology [15,16]. We transiently expressed IBV E, ssIBV
E, and FLAG-IBV E in HeLa cells and probed their membrane
topology using selective permeabilization of the plasma membrane
with digitonin, followed by indirect immunofluorescence micros-
copy. As a control we co-expressed a luminal ER protein (CFP-
KDEL) along with a protein present on the cytoplasmic side of the
Golgi complex (golgin160-Myc). As expected, the cytoplasmic
epitope of golgin160-Myc was accessible after either Triton X-100
or digitonin permeabilization, whereas the luminal epitope of
CFP-KDEL was not accessible when cells were permeabilized with
digitonin (Figure 5A). For IBV E and ssIBV E we stained for either
the N- or C-terminus using antibodies directed to either end of the
protein. We found that both IBV E and ssIBV E largely existed as
transmembrane proteins with the N-terminus in the lumen and the
C-terminus in the cytoplasm (Figure 5B). For FLAG-IBV E we
used a similar approach but stained for the N-terminus with an
anti-FLAG antibody because our anti-IBV E N-terminal antibody
was unable to recognize the modified N-terminus. The results
showed that FLAG-IBV E had both the N- and C-termini in the
cytoplasm (Figure 5B). We also found that the mutations did not
affect the targeting of either construct, as both colocalized with
Golgi complex markers (Figure 6A and data not shown). We
quantified the difference in the staining intensity under the
different permeabilization conditions by measuring the fluores-
cence signal for the N- and C-termini in the same cell. After
subtracting the background signal, the N:C ratio was calculated,
and normalized to the ratio from the Triton X-100 samples for
ease of comparison (Figure 5C). As expected the ratio dropped
dramatically for both IBV E and ssIBV E, but not for FLAG-IBV
E. Thus, mutant IBV E proteins predominantly adopt either a
transmembrane or membrane hairpin topology. It is worth noting
that the N:C ratio was lower for ssIBV E than for IBV E. While
this difference was not statistically significant, we speculate that
Figure 2. T16 is required for Golgi complex disruption. (A)
Indirect immunofluorescence microscopy of HeLa cells transiently
expressing IBV E, S13A, or T16A. IBV E is shown in green, GM130 is
shown in red and nuclei are shown in blue. (B) Quantification showing
the extent to which IBV E and the HD mutants disrupt Golgi complex
morphology. To determine the extent of Golgi disruption, the area
encompassing GM130 staining was measured in non-transfected cells
and in cells expressing the various E mutants as described in Materials
and Methods. Scale bars, 10 mm. Data are from three independent
experiments, N$54 for each condition. Error bars represent +/2 SEM,
and the asterisk denotes a significant increase in Golgi disruption
compared to the control by Student’s t-test (p#5.4610
23).
doi:10.1371/journal.ppat.1002674.g002
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membrane hairpin.
A Transmembrane Topology is Required for Disrupting
the Secretory Pathway
Having developed versions of IBV E that adopt a unique
orientation in the membrane, we determined if topology was
important for disrupting the Golgi complex. IBV E, ssIBV E, and
FLAG-IBV E were transiently expressed in HeLa cells and
subjected to indirect immunofluorescence microscopy. Staining for
IBV E and GM130 revealed that ssIBV E disrupted Golgi
complex morphology to a similar degree as IBV E (Figure 6A and
B). However, FLAG-IBV E had no effect on Golgi complex
morphology (Figure 6A and B). This result suggests that the
transmembrane topology is necessary for inducing Golgi complex
disassembly. Since IBV E with mutations at T16 did not disrupt
the secretory pathway, it was important to confirm that these
mutations did not disrupt topology. Indeed, the selective
permeabilization assay demonstrated that the topology of IBV
E-T16A was identical to IBV E (Figure S2).
Next we tested whether expression of the topology constructs
affected protein trafficking. We found that ssIBV E disrupted
protein trafficking similar to IBV E (Figure 7A and B). FLAG-IBV
E did not disrupt trafficking to the same extent as ssIBV E or IBV
E but still had some effect (Figure 7A and B). This could indicate
the IBV E hairpin does have some effect on trafficking, albeit to a
smaller degree. It is also possible that a portion of FLAG-IBV E is
inserted in a transmembrane topology and this small pool of
protein is sufficient to alter trafficking, but insufficient to disrupt
the morphology of the Golgi complex.
The addition of a FLAG tag to the N-terminus of IBV E could
result in a number of effects beyond changing the topology of IBV E.
Thus, we generated a version of IBV E that had a canonical signal
sequence, followed by a FLAG tag on the N-terminus (ssFLAG-IBV
E).When transientlyexpressed in HeLa cells,ssFLAG-IBV E wasnot
targeted as well to the Golgi complex as the other constructs (Figure
S3A). Also, selective permeabilization showed that a larger portion of
the N-terminus was in the cytoplasm compared to ssIBV E (Figure
S3B). These observations suggest that the FLAG tag may alter
insertion and targeting when added behind a cleaved signal sequence.
However, even with these caveats, ssFLAG-IBV E still disrupted
traffickingsimilarlytoIBVEandssIBVE(FigureS3D).ssFLAG-IBV
Ealso disrupted the Golgicomplex,but toa lowerdegree than IBV E
or ssIBV E, possibly due to less efficient targeting (Figure S3C). These
results strongly support our interpretation of the importance of
topology and IBV E function.
Role of Membrane Topology in Assembly
To test how the membrane topology of IBV E affects particle
assembly, we assayed IBV E, ssIBV E and FLAG-IBV E in a VLP
Figure 3. Substitution with other polar uncharged residues is not tolerated at position 16. (A) Multiple sequence alignment of CoV E
proteins. Negatively charged residues are colored red, positively charged residues are colored in blue and polar uncharged residues are colored in
yellow. The box encompasses the hydrophobic domain of IBV E, and the arrow denotes position 16 in IBV E. (B) VSV G pulse-chase coupled with endo
H digestion as described in Figure 1. Mutation of T16 to S, N, or Q does not restore the ability of the protein to disrupt trafficking of VSV G through
the Golgi complex. Data are from at least two independent experiments. Error bars represent +/2 SEM. (C) IBV E protein with S, N or Q substituted for
T16 does not induce Golgi complex disassembly (See Figure 2 for description of quantification). Data are from 3 independent experiments, N$48 for
each condition. Error bars represent +/2 SEM, and the asterisk denotes a significant increase in Golgi disruption compared to the control by Student’s
t-test (p#3610
25).
doi:10.1371/journal.ppat.1002674.g003
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encoding IBV M and IBV N in HeLa cells and determined the
amount of VLPs released into the supernatant by immunoblotting
(Figure 8A and B). Cells expressing ssIBV E produced less VLPs
than those expressing wild-type IBV E, suggesting that the
transmembrane topology can at least partially drive assembly,
possibly by inducing membrane curvature in a lattice of IBV M. In
support of this result, ssFLAG-IBV E also produced reduced levels
of VLPs (Figure S3E). Cells expressing FLAG-IBV E produced
almost no VLPs, indicating that the hairpin topology alone may
not support the production of particles. This result is harder to
interpret. It is not clear if the membrane hairpin is unable to drive
assembly, release, or both.
Discussion
We reported previously that replacing the entire HD of IBV E
with a heterologous sequence eliminated disruption of the
secretory pathway in transfected cells, and dramatically reduced
the release of infectious virus from infected cells [21]. Total
particle release was only modestly affected, however, suggesting
that the HD of IBV E is important for preventing damage to
virions during egress. Here we have shown that a single amino
acid in the HD of IBV E (T16) is critical for disruption of the
secretory pathway in cells expressing IBV E, but was not required
for VLP production. This result suggests that the alteration to the
secretory pathway is uncoupled from the role of E in assembly.
Additionally, we generated versions of IBV E that adopted either a
transmembrane or membrane hairpin topology. Using these
mutants, we showed that a transmembrane topology was required
for secretory pathway disruption. The residue equivalent to T16 in
SARS-CoV E, N15, is predicted to lie in the pore region of a
homo-pentamer [7]. Studies on a lysine-flanked peptide of the
SARS-CoV E HD showed that N15 was important for the ion
channel activity of the peptide in planar lipid bilayers [25]. Since
we found that a transmembrane topology and T16 are required
for disrupting the secretory pathway, and both are predicted to be
important for ion channel activity, it is certainly possible that the
disruption of the secretory pathway is due to the putative channel
activity of IBV E. Alteration of Golgi complex structure and
disruption of protein traffic occur when the ion balance at the
Golgi complex is disrupted [26–29]. While an active ion channel
at the Golgi complex could explain our observations, how altering
the ion balance of secretory organelles might facilitate release of
infectious particles remains unknown. We speculate that the
demands of trafficking large virion cargo require the expansion of
the Golgi complex cisternae, which may be achieved by changing
the luminal ion concentration. Alternatively, a change in luminal
environment may inactivate proteases present in the secretory
pathway, thus protecting the virions from degradation that could
render them non-infectious. The membrane rearrangements
observed in CoV-infected cells are likely due at least partially to
a disruption in the luminal microenvironment, although syncytia
formation also contributes [19,20]. Expression of the E protein in
the absence of infection allowed us to assess its contribution to
membrane rearrangements directly.
Many viruses encode small membrane proteins that have ion
channel activity [30]. As a group these proteins are referred to as
viroporins. The best studied viroporin is influenza M2, which
forms a tetrameric pH-activated proton channel [31]. The M2
channel acidifies the interior of the virion during entry to aid in
unpacking the genome [32]. For some strains of influenza virus,
M2 also plays an important role in the secretory pathway where it
raises the pH of the trans-Golgi to prevent the premature activation
of the fusion protein [29,33,34]. Hepatitis C virus (HCV), like
CoVs, assembles intracellularly and must navigate the secretory
pathway for release. Interestingly, HCV encodes a proton selective
viroporin, p7 [35–37]. While the exact role p7 is not fully
understood, it is important in the assembly and release of HCV
virions, and expression of p7 leads to the alkalinization of secretory
organelles [37–39]. It is possible that HCV-p7 and CoV E have
analogous roles during infection for altering the secretory pathway
to promote the release of virions. Viroporins appear to play
important roles in the assembly and trafficking of many viruses;
understanding their exact role(s) is important as they represent
good targets for therapeutic intervention via small molecule
inhibitors.
While T16 in IBV E is required for disrupting the secretory
pathway, it is not important for virus assembly as judged by VLP
production. Our VLP results also suggest that disruption of the
secretory pathway is not required for virus egress, since the T16A
mutant produced the same level of VLPs as the wild-type E
protein. However, the VLP assay does not allow measurement of
infectivity, which was greatly reduced for particles released from
Figure 4. Mutations at T16 in IBV E support VLP production. (A)
Immunoblot showing the amount of IBV N, M, and E in cells and
released as VLPs. (10% of cell fraction, 100% of VLP fraction) (B)
Quantification of immunoblot data showing the amount of M released
with no E, IBV E, T16A, T16S, T16Q or T16N. Data were normalized to the
amount of M expressed in each sample, and the amount of M released
with IBV E was set to 1 for ease of comparison. Data are from three
independent experiments. Error bars represent +/2 SEM, and the
asterisk denotes a significant decrease in VLP level compared to IBV E
by Student’s t-test (p,4610
23).
doi:10.1371/journal.ppat.1002674.g004
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HD [21]. Another difference between infection and the VLP assay
is that more particles are produced in a shorter time during
infection, it is likely then that the stress on the secretory pathway is
much more robust during infection. Thus, the VLP assay may not
accurately reflect virion trafficking during infection. To measure
the effect of T16 on virion trafficking, assays that measure both the
amount, rate, and route of infectious particle trafficking are
necessary. A future goal will be to analyze recombinant viruses
carrying mutations at T16 with quantitative trafficking assays.
If CoV E is important for the release of infectious particles, why
do some CoVs show only a modest reduction in infectivity when E
is deleted [40]? Moreover, why do we only observe a measurable
disruption in the secretory pathway with IBV E and not the E
proteins from other CoVs? The answer to these questions may lie
in the exact role(s) that the CoV E protein plays for each virus.
While the E proteins from different CoVs share a similar domain
structure, there is large variation in their primary sequence.
Additionally, the requirement of CoV E for the production of
infectious virus is not consistent between different CoVs. The E
Figure 5. Generation of IBV E mutants that adopt distinct membrane topologies. (A) When cells are permeabilized with Triton X-100 both
lumen (CFP-KDEL) and cytoplasmic (golgin160-Myc) epitopes are detected. Permeabilization with digitonin allows detection of the cytoplasmic
epitope, but not the luminal epitope. (B) Selective permeabilization of cells expressing IBV E, ssIBV E, and FLAG-IBV E. The N-terminus of IBV E and
ssIBV E was detected using a rabbit antibody to the N-terminus. The N-terminus of FLAG-IBV E was detected using a mouse anti-FLAG antibody. The
C-terminus of each construct was detected using a rat-antibody against the C terminus of IBV E. Scale bars, 10 mm. Cartoons at the bottom of each
panel show the predicted topology for each protein. (C) Quantification of topology shown as N-terminus to C-terminus fluorescence ratio (see
Material and Methods). The data are normalized to the ratio from the Triton X-100 permeabilized samples. Data are from at least 2 independent
experiments with N$17 for each condition. Error bars represent +/2 SEM, and the asterisk denotes a significant decrease in N:C between the Triton
X-100 and digitonin signal by Student’s t-test (p#3.4610
23).
doi:10.1371/journal.ppat.1002674.g005
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PLoS Pathogens | www.plospathogens.org 7 May 2012 | Volume 8 | Issue 5 | e1002674protein of the TGEV is essential for the production of infectious
virus [18]. However, a version of MHV lacking the E gene can
replicate, albeit at a greatly reduced titer [41]. Finally, a
recombinant version of SARS-CoV with E deleted shows only a
modest reduction in infectivity when passaged in cultured cell lines
[40]. These results suggest that CoV E may have evolved to
perform divergent functions in different CoVs. Somewhat
surprisingly then, it was reported that the E protein from several
different CoVs, including IBV E, could substitute for MHV E
during infection [42]. Even more striking, when MHV DE was
passaged, revertants were recovered with a partial duplication of
the M gene (consisting of the N terminus and three transmem-
brane domains but lacking the C-terminal tail) that were able to
largely compensate for the lack of E [43]. Taken together, these
results show that at least some function(s) of the E protein are
conserved among CoVs. However, the requirement for its
function(s) may vary significantly due to the compensatory action
of other viral proteins or differences in cell and tissue types
infected. Of all the CoVs whose E proteins were tested here, IBV is
the only one with an avian host. The requirements for assembly
and release in avian species may be slightly different than in
mammals. We tested whether the disruption of the secretory
pathway caused by IBV E occurred in DF-1 chicken fibroblasts
(cultured at 39uC), and found that the secretory pathway was
disrupted similar to HeLa cells (unpublished data). Another
potential difference is the cell type in which each virus replicates.
Figure 6. The transmembrane topology of IBV E promotes disruption of the Golgi complex. (A) Indirect immunofluorescence microscopy
of HeLa cells transiently expressing IBV E, ssIBV E, or FLAG-IBV E. The E protein is shown in green, GM130 is shown in red, and nuclei are shown in
blue. Scale bars, 10 mm. (B) Quantification of Golgi complex disruption in HeLa cells expressing IBV E, ssIBV E, or FLAG-IBV E (see Figure 2 for
description of quantification). Data are from 3 independent experiments with N$48 for each condition. Error bars represent +/2SEM, and the asterisk
denotes a significant increase in Golgi disruption compared to the control by Student’s t-test (p#7.8610
26).
doi:10.1371/journal.ppat.1002674.g006
Figure 7. The transmembrane topology of IBV E promotes disruption of protein trafficking. (A) VSV G pulse-chase coupled with endo H
digestion as described in Figure 1. The mature (**) and immature (*) forms are indicated. (B) Quantification of the pulse-chase data. Both ssIBV E and
IBV E dramatically affect protein trafficking, while FLAG-IBV E has a more modest effect. Data are from 3 independent experiments. Error bars
represent +/2 SEM.
doi:10.1371/journal.ppat.1002674.g007
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could be an important factor. Another possibility is that the
compartmental localization of the E proteins may vary in the
absence of the other viral proteins and the impact of each CoV E
on the secretory pathway could depend on the Golgi subcompart-
ment in which it is localized. This possibility could be addressed by
immunoelectron microscopy on cells expressing the various E
proteins. There is a notable difference in the ion specificity and
channel behavior among the different E protein channels in planar
lipid bilayers [4,5]. Unlike the other CoV E channels character-
ized, the IBV E channel demonstrated rectification, where ions are
moved predominately in one direction [5]. Additionally, the IBV
E channel is insensitive to the small molecule HMA, unlike the
other CoV E proteins tested [5,9]. If the ion specificity or activity
varies between the CoV E proteins, it could certainly explain the
differences in behavior reported here. The best way to study these
differences would require electrophysiological measurements using
patch clamp analysis on purified Golgi membranes. This approach
would allow the direct measurement of the CoV E protein in its
natural membrane with the proper post-translational modifica-
tions, but will be very technically challenging. One last point is that
the sequences of the CoV E proteins are highly variable. Of note,
IBV E is significantly larger and contains more polar residues in its
HD than the other CoV E proteins (see Figure 3A). It will be
important to determine how these differences relate to the function
of the proteins. This could be addressed by determining how
chimeric proteins affect the secretory pathway and virus
replication.
Previous reports on CoV E protein topology have suggested that
it may exist either as a transmembrane protein or as a membrane
hairpin with both the N- and C-termini in the cytoplasm. The
ability to adopt multiple membrane topologies could be a
mechanism to increase the number of protein functions within
the constrictions of genome size. Here, we generated mutant
versions of IBV E that adopted either a membrane hairpin or
transmembrane topology. We found that the transmembrane
version of the protein behaved largely like IBV E, with the
exception that it was unable to drive VLP production to the same
degree. The membrane hairpin version of IBV E was unable to
disrupt the secretory pathway or drive VLP production. These
data suggest that IBV E largely functions as a transmembrane
protein, with no apparent role for the membrane hairpin.
However, such conclusions should be drawn with caution. While
we determined that ssFLAG-IBV E behaved largely like ssIBV E,
addition of the FLAG tag onto the N-terminus of IBV E could
have any number of off-target effects, especially when considering
the interaction of the E protein with M. We attempted to generate
a membrane hairpin using several different strategies, including
altering the charge distribution on either end of the HD, extending
the N terminus with different tags, and shortening the C-terminus.
Our only successful strategy was adding the FLAG tag onto the N-
terminus. It should be noted that all reports of CoV E
demonstrating that it adopts a membrane hairpin upon expression
have been carried out using N-terminally tagged proteins [15,16].
In fact the most recent data on the topology of SARS-CoV E using
the untagged protein and antibodies directed to either terminus
show that the predominant topology is Nexo,C cyto [13]. What
remains unclear is if a membrane hairpin plays a role during
infection. It is possible that a portion of the E protein adopts a
membrane hairpin topology. We did observe a small difference
between ssIBV E and IBV E when we quantified the signal from
our selective permeabilization experiment. A small amount of
CoV E in the membrane hairpin conformation could play a
catalytic role during assembly, and while not necessarily required
for assembly, it may increase the efficiency of assembly. This
would explain why FLAG-IBV E could not support VLP
production on its own. This idea could be addressed by developing
infectious clones of IBV carrying the topology mutants of IBV E
and examining particle production biochemically and by electron
microscopy of infected cells. Also of interest is the mechanism for
generation of multiple topologies. A transmembrane topology is
likely generated through the canonical signal recognition particle
pathway like other type III membrane proteins [23], but the
generation of a hairpin could involve a different mechanism. One
could speculate that a hairpin could be generated through post-
translational insertion, possibly directly into the target membrane
[44].
Figure 8. Neither ssIBV E or FLAG-IBV E produce normal levels
of VLPs. (A) Immunoblot showing the amount of IBV N, M, and E in
cells and released as VLPs. (10% of cell fraction, 100% of VLP fraction) (B)
Quantification of immunoblot data showing the amount of M released
with no E, IBV E, ssIBVE, or FLAG-IBV E. Data were normalized to the
amount of M expressed in each sample, and the amount of M released
with IBV E was set to 1 for ease of comparison. Data are from at least
five independent experiments. Error bars represent +/2 SEM, and the
asterisk denotes a significant decrease in VLP level compared to IBV E
by Student’s t-test (p#0.01).
doi:10.1371/journal.ppat.1002674.g008
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PLoS Pathogens | www.plospathogens.org 9 May 2012 | Volume 8 | Issue 5 | e1002674The IBV E protein is a multifunctional viral protein that plays a
role in both the assembly and release of infectious virus. The exact
mechanism by which the protein alters the secretory pathway to
facilitate infectious particle release is still unknown, but may
depend on a single amino acid in the HD. Identification of the
mechanism will be a big step in understanding the interplay
between the secretory pathway and CoV trafficking. Also of
interest is how E protein function varies among CoVs and what
underlies any difference(s). Understanding these questions will
provide insight into both therapeutic approaches to CoV infection
and increase our understanding of how CoVs use the host
secretory pathway to their advantage.
Materials and Methods
Cell Culture and Transfection
HeLa cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) (Invitrogen) with 10% Fetal Bovine Serum (FBS)
(Atlanta Biologicals), and 0.1 mg/ml Normocin (InvivoGen) at
37uC under 5% CO2. Transient transfection of HeLa cells was
performed using Fugene6 or XtremeGene 9 (Roche) according to
the manufacturer’s protocol. Experiments were performed 18–
22 hours post transfection unless noted otherwise.
Plasmids and Mutagenesis
The expression plasmids for IBV E, VSV G and IBV M have
previously been described [12,21,45]. The sequence for IBV N
was amplified by RT-PCR of RNA from IBV infected cells. The
sequence was inserted into pcDNA3.1 using BamHI and EcoRI
sites, and subcloned into pCAGGS using KpnI and XhoI.
Mutations of the HD of IBV E were introduced via Quikchange
(Stratagene) site directed mutagenesis. ssIBV E was generated by
inserting a BglII site directly upstream of the start codon of IBV E
using Quikchange mutagenesis. The vector was digested with
EcoRI and BglII and synthetic oligonucleotides encoding the
signal sequence of VSV G (MKCLLYLAFLFIGVNCRS) with
flanking EcoRI and BlgII sites was ligated upstream of the start of
IBV E to generate ssIBV E. The FLAG-IBV E construct was made
in a similar way. A sequence encoding an initiation codon and the
FLAG epitope (MDYKDDDDK) with flanking BglII sites was
ligated directly upstream of the start codon of IBV E. ssFLAG E
was generated by ligating the same FLAG epitope
(MDYKDDDDK) into the ssIBV E construct after digestion with
BglII. pCAGGS SARS E (Urbani) has been previously described
[46]. Plasmids containing the coding sequences for MHV E (A59)
and TGEV E (Purdue p115) were kindly provided by Paul Masters
(Wadsworth Center, Albany, NY). The coding sequence of MHV
E and TGEV E were PCR amplified and inserted into pCAGGS
using EcoRI and KpnI or EcoRI and XhoI respectively. The
CFP-KDEL expression vector was from clontech. The construct
consists of a signal sequence followed by the cyan fluorescent
protein and a KDEL ER retrieval sequence in the C-terminal tail
of the protein. Golgin160-myc has been previously described [47].
Antibodies
The following antibodies have been previously described:
Rabbit and rat antibodies recognizing the C termini of IBV E,
rabbit antibody recognizing the N terminal portion of IBV E [12],
rabbit anti-IBV M used for immunoblotting [48], and the rabbit
anti-VSV polyclonal antibody used for immunoprecipitation [49].
The rabbit anti-MHV E and rabbit anti-TGEV E used for
immunofluorescence were kind gifts from Paul Masters, and have
been previously described [42]. The rabbit anti-IBV N antibody
was a kind gift from Ellen Collisson and has been previously
described [50]. Mouse anti-GM130 was from BD Biosciences,
rabbit anti-GFP was from Molecular Probes, mouse anti-FLAG
M2 was from Sigma, and the monoclonal mouse anti-Myc
antibody (clone 9E10) was from Roche Molecular Biochemicals.
The Alexa Fluor 488 conjugated donkey anti-rabbit IgG, Alexa
Fluor 488 conjugated donkey anti-mouse IgG, Alexa Fluor 568
conjugated donkey anti-rabbit IgG and Alexa Fluor 568
conjugated anti-mouse IgG were from Molecular Probes. The
Texas Red conjugated donkey anti-rat was from Jackson
ImmunoResearch Laboratories. The horseradish peroxidase
conjugated donkey anti-rabbit antibody was from Amersham.
Multiple Sequence Alignment
Multiple sequence alignment of CoV E proteins was carried out
using ClustalW2 at the European Bioinformatics Institutes server
[51]. The figure was generated using jalview version 2 [52].
GenBank accession numbers of the sequences used in the
alignment are as follows: TGEV E (ABG89321), IBV E
(CAC39117), SARS E (NP_828854.1), MHV E (ACO72886),
FIPV E (AAY16378), HCoV HKU1 (YP_173240), PEDV
(NP_598312), PHEV (YP_459955), Bovine CoV (NP_150081),
HCoV OC43 (NP_937952), and HCoV 229E (NP_073554).
Pulse-Chase Endo H assay
HeLa cells were transfected with pCAGGS VSV G (1 mg) along
with either a control plasmid (0.5 mg pCAGGS IBV M) or a
pCAGGS E construct (0.5 mg). Cells were incubated in cysteine-
methionine free DMEM for 15 min, labeled with 50 mCi of
Expre
35S
35S[
35S]-methionine-cysteine (Perkin Elmer) in cysteine-
methionine free DMEM for 20 min, and chased in normal growth
medium. Prior to collection, labeled cells were washed with PBS.
Samples were lysed in detergent solution with protease inhibitor
cocktail and clarified at 20,0006g. SDS was added to 0.2% and
the samples were pre-cleared with Staphylococcus aureus Pansorbin
cells. Rabbit anti-VSV antibody was added to each sample and
incubated for 209. Immune complexes were collected with 20 mlo f
washed Staphylococcus aureus Pansorbin cells and washed two times
in RIPA buffer (10 mM Tris [pH 7.4], 0.1% SDS, 1% deoxy-
cholic acid, 1% NP40, 150 mM NaCl). Immune complexes were
eluted in 1% SDS [pH 6.8] at 100uC and digested in 75 mM Na-
citrate [pH 5.5] with 0.2 ml endo H (100 units) (New England
Biolabs) at 37uC overnight. Concentrated sample buffer (200 mM
Tris-HCl [pH 6.8], 8% SDS, 60% glycerol, 0.2% bromophenol
blue) was added to each sample prior to separation on 10% SDS-
PAGE. Labeled proteins were visualized by using a Molecular
Imager FX phosphorimager (Bio-Rad) and quantified using
Quantity One software (BioRad).
Indirect Immunofluorescence Microscopy
HeLa cells plated on glass coverslips were processed for
immunofluorescence 18–22 h after transfection. For assaying
Golgi disruption in cells expressing IBV E or the HD mutants
cells were fixed in 3% paraformaldehyde for 10 min. The fixative
was quenched with PBS containing 10 mM glycine (PBS/Gly).
The cells were permeabilized in 0.5% TX-100 for 3 min and
washed in PBS/Gly. Cells were stained with rabbit anti-IBV E
(1:1000) and mouse anti-GM130 (1:1000). Secondary antibodies
were Alexa Fluor 488 conjugated anti-rabbit IgG (1:1000), Alexa
Fluor 568 conjugated anti-mouse IgG (1:1000). DNA was stained
prior to imaging with Hoechst 33285 (0.1 mg/ml). All images were
collected using an Axioscop microscope (Zeiss) equipped for
epifluorescence using an ORCA-03G charge-coupled-device
camera (Hamamatsu, Japan). Data analysis was done using
iVision software (BioVision Technologies) and Microsoft Excel.
Multiple Functions of the Coronavirus E Protein
PLoS Pathogens | www.plospathogens.org 10 May 2012 | Volume 8 | Issue 5 | e1002674To determine if the Golgi complex was disrupted in cells
expressing IBV E or its mutants, the staining for the Golgi
complex (as judged by the GM130 staining) was outlined. The
area encompassing the Golgi complex was measured for cells
expressing IBV E, the HD mutants, or non-transfected cells. A
normal Golgi was determined to be the average area of non-
transfected cells +/21.5 standard deviations. Cells with a staining
area larger than this were scored as disrupted. The percent
disrupted was calculated by dividing the number of cells scored as
disrupted by the total number of cells measured.
Selective Permeabilization of the Plasma Membrane
HeLa cells were transfected with CFP-KDEL (0.2 mg) and
golgin160-Myc (1 mg) for control samples or with IBV E (0.5 mg),
pCAGGS-ssIBVE (1.5 mg), pCAGGS-FLAG-IBV E (0.5 mg),
pCAGGS ssFLAG-IBV E (0.5 mg), pCAGGS IBV E T16A
(0.5 mg). For the Triton samples the protocol listed above was
followed. For selective permeabilization of the plasma membrane,
cells were washed with a cold KHM (20 mM HEPES [pH 7.4],
110 mM KOOCH3, 2 mM Mg(OOCH3)2) and kept on ice. The
cells were permeabilized with 75 mg/ml digitonin (EM Sciences)
for 10 min. The digitonin solution was removed and the cells were
rinsed twice with cold KHM. The cells were moved to room
temperature and fixed with 3% paraformaldehyde for 10 min.
The control cells were incubated with mouse anti-Myc (1:2) and
rabbit anti-GFP (1:500). The C-terminus of IBV E, ssIBV E, and
FLAG-IBV E were detected using a C-terminal rat anti-IBV E
antibody (1:500). The N-terminus of IBV E and ssIBV E was
detected using a rabbit anti N-terminal IBV E antibody (1:100).
The N-terminus of FLAG-IBV E was detected using a mouse anti-
FLAG antibody (1:500). Secondary antibodies were The Alexa
Fluor 488 conjugated donkey anti-rabbit IgG (1:1000), Alexa
Fluor 568 conjugated anti-mouse IgG (1:1000), and Texas Red
conjugated donkey anti-rat (1:500). DNA was stained prior to
imaging with Hoechst 33285 (0.1 mg/ml).
For quantitation, images of equal exposure time were taken of
both the Triton X-100 and digitonin samples for each antibody.
To obtain the staining intensity, an initial background measure-
ment was obtained on the C-terminal staining by drawing a region
of interest (ROI) around an untransfected cell and measuring the
fluorescence intensity. The exact same ROI and measurement was
then made on the corresponding N-terminal image. Next, an ROI
was drawn around a cell showing C-terminal staining and the
mean fluorescence intensity was measured. Again, the exact same
ROI was overlaid onto the corresponding N-terminal image and
the mean fluorescence intensity was measured. The ratio of N- to
C-terminal staining was calculated by first subtracting the
background from each measurement, and then dividing the N-
terminal value by the C-terminal value. For the data shown, the
final ratios were normalized so that the signal ratio in the Triton
X-100 samples was equal to 1.
Virus Like Particle Isolation
HeLa cells were plated in 6 cm dishes and transfected with a
combination of plasmids encoding IBV M (2 mg), IBV N (1.5 mg),
IBV E (0.1 mg), ssIBV E (0.4 mg), FLAG-IBV E (0.2 mg), ssFLAG
IBV E (0.2 mg), T16A (0.1 mg), T16S (0.1 mg), T16N (0.1 mg) and
T16N (0.1 mg). Samples were prepared 42–48 hours post
transfection. The medium was clarified via centrifugation at
45006g for 20 min. The supernatant was loaded onto a 20%
sucrose cushion and centrifuged at 234,0006g in a TLA-110 rotor
for 60 min. The supernatant was discarded and the pellet
containing the VLPs was resuspended in 16 glycoprotein
denaturation buffer (New England Biolabs) containing 100-fold
concentrated protease inhibitor cocktail (Sigma). To collect the cell
fraction, dishes were washed with cold PBS. The cells were
scraped off the dish in 1 ml PBS and pelleted at 40006g for 2 min.
The pellet was resuspended in detergent solution and insoluble
material was pelleted at 20,0006g for 1 min. 106 glycoprotein
denaturation buffer was added to 16. Both the VLP and cell
fractions were heated at 100uC for 1 min. Both samples were
digested with PNGase F (New England Biolabs) according to the
manufacturer’s protocol. After digestion concentrated sample
buffer was added to a final concentration of 50 mM Tris
[pH 6.8], 2% SDS, 0.05% bromophenol blue, 15% glycerol.
Samples were separated on 15% PAGE gels (10% of cell fraction,
100% of VLP fraction) and transferred to polyvinylidene fluoride
Immobilon membranes (Millipore). Proteins were detected using
rabbit anti-IBV N (1:10,000), rabbit anti-IBV M (1:5000) and
rabbit anti-IBV E (1:10,000) primary antibodies and horseradish
peroxidase conjugated donkey anti-rabbit IgG (1:10,000) second-
ary antibody. After incubation in secondary antibody, the
membrane was incubated with HyGlo Quick Spray chemilumi-
nescent detection reagent (Denville Scientific Inc.). Images were
collected using a Versa Doc model 5000 (Bio-Rad) and Quantity
One software.
Cycloheximide Chase to estimate half-lives of CoV E
proteins
HeLa cells were treated with 100 mg/ml cycloheximide (Sigma)
diluted into culture media at 18 hours-post transfection. Cells were
fixed and prepared for immunofluorescence as described above at
0, 3, and 6 hrs after cycloheximide treatment. Images were
collected from each time point at the same exposure time, and the
mean fluorescence intensity was determined for cells expressing
the E protein. The half-lives of each E protein were calculated by
plotting the signal intensity versus time on a semi-log graph.
Supporting Information
Figure S1 Expression of other CoV E proteins does not disrupt
Golgi complex morphology. Indirect immunofluorescence micros-
copy on cells expressing TGEV E, MHV E, or SARS-CoV E. The
E protein is shown in green, GM130 is shown in red, and nuclei
are shown in blue. Scale bars, 10 mm.
(TIF)
Figure S2 IBV E T16A has the same topology as IBV E.
Selective permeabilization was carried out on cells expressing IBV
E T16A. The N- and C-termini were detected using antibodies
specific to each terminus. The histogram shows quantification of
topology as a ratio of the N-terminus to C-terminus fluorescence
signal (see Material and Methods). The data are normalized to the
ratio from the Triton X-100 permeabilized samples. Data are from
at least 2 independent experiments with N$16 for each condition.
Error bars represent +/2 SEM, and the asterisk denotes a
significant difference between the Triton X-100 and digitonin
signal by Student’s t-test (p#2.5610
27).
(TIF)
Figure S3 ssFLAG-IBV E behaves similarly to ssIBV E. (A)
Indirect immunofluorescence microscopy on cells expressing
ssFLAG-IBV E. The E protein is shown in green, GM130 is
shown in red, and nuclei are shown in blue. Scale bar, 10 mm. (B)
Selective permeabilization was carried out on cells expressing
ssFLAG-IBV E. The N- terminus was detected using an anti-
FLAG antibody and the C-terminus was detected using a Rat anti-
IBV E antibody. The histogram shows quantification of topology
as a ratio of the N-terminus to C-terminus fluorescence signal (see
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the Triton X-100 permeabilized samples. Data are from at least 2
independent experiments with N$22 for each condition. Error
bars represent +/2 SEM, and the asterisk denotes a significant
difference between the Triton X-100 and digitonin signal by
Student’s t-test (p#1610
28). (C) Quantification of Golgi complex
disruption in HeLa cells expressing ssFLAG-IBV E (see Figure 2
for description of quantification). Data are from 2 independent
experiments with N$37 for each condition. Error bars represent
+/2SEM. (D) The graph shows the quantification of VSV G
pulse-chase coupled with endo H digestion as described in
Figure 1. ssFLAG-IBV E dramatically affects cargo trafficking.
Data are from 2 independent experiments. Error bars represent
+/2 SEM. (E) A VLP assay was performed and quantified as
described in Figure 4 for ssFLAG-IBV E. ssFLAG-IBV E was
compromised in the production of VLPs compared to IBV E. Data
are from at least five independent experiments. Error bars
represent +/2 SEM, and the asterisk denotes a significant
decrease in VLP level compared to IBV E by Student’s t-test
(p,1.4610
24).
(TIF)
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